Be part of the knowledge - Global Oncology Academy

Popular

- Timothy A. McCarthy, MD
  Peer
2
CME/CE
Precision Oncology: Incorporating Next Generation Sequencing (NGS) in NSCLC
- James L. Gulley, MD, PhD, FACP
  Peer
- Scott Kopetz, MD, PhD, FACP
  Peer
- Luis Paz-Ares, MD, PhD
  Peer
5
CME/CE
Promising Bifunctional Agents in Immuno-Oncology: A Roundtable Discussion wit...
- Sagar Lonial, MD, FACP
  Peer
6
CME/CE
Clinical Debates in Multiple Myeloma: Putting Evidence Into Context
- Mary Reid, PhD
  Peer
6
CME/CE
Effective Communication: Improving Patient’s Understanding of Cancer Risk
- John J. Russell, MD
  Peer
- David A. Reardon, MD
  Peer
74
CME/CE
Antibody-Drug Conjugates in Glioblastoma Multiforme: Finding Ways Forward
- Shira Johnson, MD
  Peer
- Ronald DeMatteo, MD, FACS
  Peer
12
Medical Breakthroughs from Penn Medicine
What to Know About a State-of-the-Art Approach to GIST Treatment

Expert Perspectives

- Athanassios Argiris, MD, PhD, FACP
  Peer
2
Immuno-Oncology (IO) Updates
Role of Immunotherapy in Head & Neck Cancer
4
FAQs with Key Opinion Leaders
Recent Breakthroughs in Head and Neck Cancer
2
FAQs with Key Opinion Leaders
Management of Head & Neck Cancer
2
FAQs with Key Opinion Leaders
Management of Recurrent Squamous Cell Carcinoma of the Head & Neck
- Tanguy Seiwert, MD
  Peer
3
FAQs with Key Opinion Leaders
Current Recommendations: HPV Tumors in Head & Neck Cancers
3
Resources
Colorectal Cancer Physician Resources
- Makoto Tahara
  Peer
5
Interviews
Patient Case Study: Role of Cetuximab in treatment of SCC Head and Neck Cance...
9
Interviews
Interview with Makoto Tahara, MD, PhD | Japan

Join the Global Oncology Academy of learners.
Registration is free and easy.